Lipoprotein(a) is the best single marker in assessing unstable angina pectoris

Cardiology Research and Practice

Volumn 1, Issue 1, 2011, Pages

  Vlahović, Predrag ^b   Djordjević, Vidosava B ^a   Ćosić, Vladan ^b   Stojanović, Ivana ^a   Kundalić, Slavica ^b   Zvezdanović, Lilika ^b   Deljanin Ilić, Marina ^c   Popović, Lidija ^a  

^a Faculty of Medicine   (Serbia)

^b Clinical Center   (Serbia)

^c Institute for Cardiovascular and Rheumatic Diseases   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEOPTERIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 79959417343     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2011/175363     Document Type: Article

References (29)

1. Ross R., Atherosclerosisan inflammatory disease New England Journal of Medicine 1999 340 2 115 126
2. Taskinen M. R., Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 2003 46 6 733 749
3. Williams K. J., Tabas I., Lipoprotein retention- and clues for atheroma regression Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 8 1536 1540 (Pubitemid 41098918)
4. Le N. A., Walter M. F., The role of hypertriglyceridemia in atherosclerosis Current Atherosclerosis Reports 2007 9 2 110 115 (Pubitemid 47376981)
5. Breslow J. L., Cardiovascular disease burden increases, NIH funding decreases Nature Medicine 1997 3 6 600 601 (Pubitemid 27264961)
6. Braunwald E., Shattuck lecture cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities New England Journal of Medicine 1997 337 19 1360 1369 (Pubitemid 27467771)
7. Packard C. J., LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow Current Medical Research and Opinion 1996 13 7 379 390 (Pubitemid 126699621)
8. Jialal I., Stein D., Balis D., Grundy S. M., Adams-Huet B., Devaraj S., Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels Circulation 2001 103 15 1933 1935 (Pubitemid 32322218)
9. Kinlay S., Schwartz G. G., Olsson A. G., Rifai N., Leslie S. J., Sasiela W. J., Szarek M., Libby P., Ganz P., High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study Circulation 2003 108 13 1560 1566 (Pubitemid 37187781)
10. Muhlestein J. B., Anderson J. L., Horne B. D., Carlquist J. F., Bair T. L., Bunch T. J., Pearson R. R., Early effects of statins in patients with coronary artery disease and high C-reactive protein American Journal of Cardiology 2004 94 9 1107 1112 (Pubitemid 39424210)
11. Albert M. A., Danielson E., Rifai N., Ridker P. M., Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study Journal of the American Medical Association 2001 286 1 64 70 (Pubitemid 32606333)
12. Jin Y. P., Qin G. M., Zhang S. Z., Li C. J., Xu G., Clinical evaluation of risk factors for coronary heart disease Zhonghua Yu Fang Yi Xue Za Zhi 2003 37 2 98 101
13. Jrgens G., Taddei-Peters W. C., Kltringer P., Petek W., Chen Q., Greilberger J., Macomber P. F., Butman B. T., Stead A. G., Ransom J. H., Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease Stroke 1995 26 10 1841 1848
14. Hamm C. W., Braunwald E., A classification of unstable angina revisited Circulation 2000 102 1 118 122 (Pubitemid 30430562)
15. Van de Werf F., Ardissino D., Betriu A., Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation European Heart Journal 2003 24 28 66
16. Djordjević V. B., Stojanović I., osi V., Zvezdanović L., Deljanin-Ilićc M., Dimic S., Kundalićc B., Cvetkovic T., Jevtovic-Stoimenov T., Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor- levels in patients with ischemic heart disease Clinical Chemistry and Laboratory Medicine 2008 46 8 1149 1155
17. Navarro-Gonzlvez J. A., Garca-Benayas C., Arenas J., Semiautomated measurement of nitrate in biological fluids Clinical Chemistry 1998 44 3 679 681 (Pubitemid 28141376)
18. Hobbs G. A., Kaplan I. V., Levinson S. S., Mechanized lipoprotein(a) assay as a marker for coronary artery disease illustrates the usefulness of high lipoprotein(a) levels Clinica Chimica Acta 1998 274 1 1 13 (Pubitemid 28243259)
19. Herrmann W., Quast S., Wolter K., Eger H., Kieig S. T., Hahmann H., Kreuter J., Molinari E., Determination of free apolipoprotein(a) in serum by immunoassay and its significance for risk assessment in patients with coronary artery disease Clinical Chemistry and Laboratory Medicine 1999 37 1 21 28 (Pubitemid 29097249)
20. Erbaci A. B., Tarakiolu M., Aksoy M., Kocaba R., Nacak M., Aynaciolu A. S., Sivrikoz C., Diagnostic value of CRP and Lp(a) in coronary heart disease Acta Cardiologica 2002 57 3 197 204 (Pubitemid 34625365)
21. Chambless L. E., Folsom A. R., Sharrett A. R., Sorlie P., Couper D., Szklo M., Nieto F. J., Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study Journal of Clinical Epidemiology 2003 56 9 880 890 (Pubitemid 37162663)
22. Bennet A., Di Angelantonio E., Erqou S., Eiriksdottir G., Sigurdsson G., Woodward M., Rumley A., Lowe G. D. O., Danesh J., Gudnason V., Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data Archives of Internal Medicine 2008 168 6 598 608 (Pubitemid 351468395)
23. Rosenson R. S., Tangney C. C., Antiatherothrombotic properties of statins: implications for cardiovascular event reduction Journal of the American Medical Association 1998 279 20 1643 1650 (Pubitemid 28248591)
24. Plenge J. K., Hernandez T. L., Weil K. M., Poirier P., Grunwald G. K., Marcovina S. M., Eckel R. H., Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction Circulation 2002 106 12 1447 1452
25. Altman R., Risk factors in coronary atherosclerosis athero-inflammations: the meeting point Thrombosis Journal 2003 1, article 4
26. Gonbert S., Malinsky S., Sposito A. C., Laouenan H., Doucet C., Chapman M. J., Thillet J., Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk Atherosclerosis 2002 164 2 305 311 (Pubitemid 35223081)
27. Ridker P. M., Rifai N., Cook N. R., Bradwin G., Buring J. E., Non-HDL cholesterol, apolipoproteins A-I and B 100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women Journal of the American Medical Association 2005 294 3 326 333 (Pubitemid 41043776)
28. Gotto A. M., Whitney E., Stein E. A., Shapiro D. R., Clearfield M., Weis S., Jou J. Y., Langendrfer A., Beere P. A., Watson D. J., Downs J. R., De Cani J. S., Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation 2000 101 5 477 484 (Pubitemid 30080860)
29. Miremadi S., Sniderman A., Frohlich J., Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders? Clinical Chemistry 2002 48 3 484 488 (Pubitemid 34176802)